Evaluation of pharmacogenetic automated clinical decision support for clopidogrel-Reference-Cited by-同舟云学术

Evaluation of pharmacogenetic automated clinical decision support for clopidogrel

Published:2024-09-11 Issue: Volume: Page:1-9
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Massmann Amanda¹²^ORCID,Heukelom Joel Van¹²^ORCID,Weaver Max¹^ORCID,Schultz April¹²^ORCID,Figueroa Debbie M²³^ORCID,Stys Adam²⁴^ORCID,Stys Tomasz P²⁴^ORCID,Christensen Kurt D⁵^ORCID

Affiliation:

1. Sanford Imagenetics, Sioux Falls, SD 57105, USA

2. Department of Internal Medicine, University of South Dakota School of Medicine, Vermillion, SD 57069, USA

3. Sanford Medical Genetics Laboratory, Sioux Falls, SD 57105, USA

4. Sanford Cardiovascular Institute, Sioux Falls, SD 57105, USA

5. Precision Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Pilgrim Health Care Institute & Harvard Medical School, Boston, MA 02215, USA

Funder

Harvard Pilgrim Health Care Institute

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14622416.2024.2394014

Reference27 articles.

1. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization

2. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update

3. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines

4. Recommendations for Clinical CYP2C19 Genotyping Allele Selection

5. PLAVIX-clopidogrel tablet. Package Insert. Sanofi-aventis U.S. LLC. September 30 2022. Accessed May 29 2024. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de8b0b67-eb25-4684-83b5-7ad785314227